Inducible production of erythropoietin using intramuscular injection of block copolymer/DNA formulation
- 5 October 2004
- journal article
- research article
- Published by Wiley in The Journal of Gene Medicine
- Vol. 7 (1) , 80-86
- https://doi.org/10.1002/jgm.631
Abstract
Background: We have previously shown that intramuscular injection of plasmid DNA formulated with a non‐ionic amphiphile synthetic vector [poly(ethylene oxide)13‐poly(propylene oxide)30‐poly(ethylene oxide)13 block copolymer; PE6400] increases reporter gene expression compared with naked DNA. We have now investigated this simple non‐viral formulation for production of secreted proteins from the mouse skeletal muscle.Methods: Plasmids encoding either constitutive human secreted alkaline phosphatase or murine erythropoietin inducible via a Tet‐on system were formulated with PE6400 and intramuscularly injected into the mouse tibial anterior muscle.Results: PE6400/DNA formulation led to an increased amount of recombinant alkaline phosphatase secreted from skeletal muscle as compared with naked DNA. In the presence of doxycycline, a single injection of 10µg plasmid encoding inducible murine erythropoietin formulated with PE6400 significantly increased the hematocrit, whereas the same amount of DNA in the absence of PE6400 had no effect. The increase in the hematocrit was stable for 42 days. The tetracycline‐inducible promoter permitted pharmacological control of hematocrit level after DNA intramuscular injection. However, 4 months post‐injection the hematocrit returned to its pre‐injection value, even in the presence of doxycycline. This phenomenon was likely caused by an immune response against the tetracycline‐activated transcription factor.Conclusions: Intramuscular injection of plasmid DNA formulated with PE6400 provides an efficient and simple method for secretion and production of non‐muscle proteins. Copyright © 2004 John Wiley & Sons, Ltd.Keywords
Funding Information
- Inserm
- Ministère délégué à la recherche et aux nouvelles technologies
- Association Française contre les Myopathies
- Vaincre la mucoviscidose
This publication has 27 references indexed in Scilit:
- Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapyGene Therapy, 2003
- Transcutaneous Ultrasound Augments Naked DNA Transfection of Skeletal MuscleMolecular Therapy, 2002
- Electroporation-Facilitated Delivery of Plasmid DNA in Skeletal Muscle: Plasmid Dependence of Muscle Damage and Effect of Poloxamer 188Molecular Therapy, 2001
- A combination of poloxamers increases gene expression of plasmid DNA in skeletal muscleGene Therapy, 2000
- Electropermeabilization of skeletal muscle enhances gene transfer in vivoGene Therapy, 1999
- Gene transfer into muscle by electroporation in vivoNature Biotechnology, 1998
- Spatial–temporal patterns of gene expression in mouse skeletal muscle after injection of lacZ plasmid DNAGene Therapy, 1997
- Polyvinyl Derivatives as Novel Interactive Polymers for Controlled Gene Delivery to MusclePharmaceutical Research, 1996
- Long-term persistence of plasmid DNA and foreign gone expression in mouse muscleHuman Molecular Genetics, 1992
- Direct Gene Transfer into Mouse Muscle in VivoScience, 1990